Ignite Creation Date:
2025-12-25 @ 4:16 AM
Ignite Modification Date:
2026-02-22 @ 9:05 AM
Study NCT ID:
NCT00530920
Status:
COMPLETED
Last Update Posted:
2014-06-06
First Post:
2007-09-17
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Tipranavir/Ritonavir Low Dose Pharmacokinetics in Treatment Naive Patients
Sponsor:
Boehringer Ingelheim
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
1182.107
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Boehringer Ingelheim, Study Chair
Old Organization:
Boehringer Ingelheim